Biodegradable Stents Market By Product (Coronary Stents, Peripheral Stents), By Material (Polymer, Metal) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

The report titled “Biodegradable Stents Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall biodegradable stents market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of products, materials, and different geographies. A key estimate for interventional cardiology discussed by Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC) in a meeting is that biodegradable stents will eventually replace conventional metallic stents in the near future. The key factors assisting the growth of biodegradable stents market are rising prevalence of coronary artery disease, increasing obesity due to sedentary lifestyle in young population, and increasing preference for biodegradable stents by cardiologists.

For the purpose of this study, the global biodegradable stents market is segmented on the basis of material type into polymer and metal. The product segment comprises market size of coronary and peripheral stents. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

The geographical segmentation of biodegradable stents market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2017 to 2025 are provided in this report.

The biodegradable stents market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Abbott Laboratories, Arterius Ltd., Boston Scientific, Inc., Biotronik, Kyoto Medical Corporation, Elixir Medical Corporation, Biosensors International, Terumo Europe NV, Ella CS, Arterial Remodeling Technologies SA, SMT (Part of Sahajanand Group of Companies), and Others.

For the purpose of this study, the global biodegradable stents market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In base year 2016, Europe accounted for the largest market share due to key drivers such as increasing public awareness related to early disease diagnosis, increasing obesity in geriatric population, and easy accessibility to modern medical facilities. According to Europe Heart Network, Each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Hospital discharge rates for CVD as a whole have increased steadily in Europe over the past 25 years. During the forecast period 2017 – 2025, Asia-Pacific was observed as the fastest growing biodegradable stents market due to key drivers such as premium price life-essential device, push strategy approached by key players to penetrate market, India observed as the largest market in Asia-Pacific with huge population, and rising healthcare expenditure assisted by mounting economic growth.

Biodegradable Stents Market

Based on the type of material, the global biodegradable stents market is segmented as follows:

  • Polymer
  • Metal

Biodegradable Stents Market

In year 2016, polymer-based biodegradable stents accounted for the largest market share due to key driving factors such as risks associated with metal-based biodegradable stents, reduces target vessel revascularization (TVR), long term safety, and reduces risk of stent thrombosis and myocardial infarction. The most competent stents available in the market are zotarolimus-eluting stent (Resolute, Medtronic), cobalt-chromium everolimus-eluting stent (Xience, Abbott Vascular), and platinum-chromium everolimus-eluting stent (Promus, Boston Scientific). According to market experts, clinical research has shown that resorbable stents, offer comparable efficacy and safety profile to drug-eluting stents. Thus, high prevalence of coronary artery diseases across the globe around the world, rising preference of cardiologists towards percutaneous coronary intervention procedures, and increasing uptake of use of stents are expected to make a significant contribution to the soaring revenue of this segment in the forecast period.

Choose License Type
Published Date:  Jun 2017
Category:  Medical Devices
Report ID:   58527
Report Format:   PDF
Pages:   120
Rating:    4.3 (65)
Connect With Us
24/7 Research Support